Piperine loaded PEG-PLGA nanoparticles: Preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy

Journal of Drug Delivery Science and Technology

Volumn 29, Issue , 2015, Pages 269-282

  Pachauri, Manendra ^a   Gupta, Enna Dogra ^a   Ghosh, Prahlad Chandra ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Apoptosis; Cancer; Drug delivery; MTT assay; Piperine; PLGA nanoparticles; Spices

Indexed keywords

MACROGOL; MUCIN 1; NANOCARRIER; PACLITAXEL; PHOSPHATIDYLSERINE; PIPERINE; POLYETHYLENE GLYCOL POLYLACTIDE CO GLYCOLIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER ADJUVANT THERAPY; CANCER RESISTANCE; CELL CYCLE; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STABILITY; ELECTRON MICROSCOPY; FEMALE; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HELA CELL LINE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; MCF 7 CELL LINE; MOLECULAR SIZE; MOLECULARLY TARGETED THERAPY; MOUSE; NANOENCAPSULATION; NANOFABRICATION; NANOPHARMACEUTICS; NONHUMAN; PIPERACEAE; PLASMA CLEARANCE; SUSTAINED DRUG RELEASE; VERO CELL LINE; WESTERN BLOTTING; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84942249232     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.08.009     Document Type: Article

References (73)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics, CA Cancer J. Clin. 61 (2011) 69-90.
2. Y.B. Sun, Y.G. Wen, Y. Yan, G.F. Li, Determination of rhodamine 123 in rat plasma utilizing liquid chromatography-tandem mass spectrometry, J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879 (2011) 3943-3948.
3. H. Chandarana, S. Baluja, S.V. Chanda, Comparison of antibacterial activities of selected species of Zingiberaceae family and some synthetic compounds, Turk. J. Biol. 29 (2005) 83-97.
4. N.V. Yanishlieva, E. Marinova, J. Pokorny, Natural antioxidants from herbs and spices, Eur. J. Lipid Sci. Tech. 108 (2006) 776-793.
5. H.F. Ji, X.J. Li, H.Y. Zhang, Natural products and drug discovery can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? Embo Rep. 10 (2009) 194-200.
6. D.J. Newman, Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J. Med. Chem. 51 (2008) 2589-2599.
7. S.C. D'Cruz, P.P. Mathur, Effect of piperine on the epididymis of adult male rats, Asian J. Androl. 7 (2005) 363-368.
8. J.S. Bang, H. Oh da, H.M. Choi, B.J. Sur, S.J. Lim, J.Y. Kim, H.I. Yang, M.C. Yoo, D.H. Hahm, K.S. Kim, Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models, Arthritis Res. Ther. 11 (2009) R49.
9. K. Srinivasan, Black pepper and its pungent principle-piperine: a review of diverse physiological effects, Crit. Rev. Food Sci. 47 (2007) 735-748.
10. A. Kumar, R.P. Raman, K. Kumar, P.K. Pandey, V. Kumar, S. Mohanty, S. Kumar, Antiparasitic efficacy of piperine against Argulus spp. on Carassius auratus (Linn. 1758): in vitro and in vivo study, Parasitol. Res. 111 (2012) 2071-2076.
11. N. Atal, K.L. Bedi, Bioenhancers: revolutionary concept to market, J. Ayurveda Integr. Med. 1 (2010) 96-99.
12. C.K. Atal, R.K. Dubey, J. Singh, Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism, J. Pharmacol. Exp. Ther. 232 (1985) 258-262.
13. R.K. Bhardwaj, H. Glaeser, L. Becquemont, U. Klotz, S.K. Gupta, M.F. Fromm, Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4, J. Pharmacol. Exp. Ther. 302 (2002) 645-650.
14. P. Makhov, K. Golovine, D. Canter, A. Kutikov, J. Simhan, M.M. Corlew, R.G. Uzzo, V.M. Kolenko, Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity, Prostate 72 (2012) 661-667.
15. H.J. Zhu, J.S. Wang, J.S. Markowitz, J.L. Donovan, B.B. Gibson, C.L. DeVane, Risperidone and paliperidone inhibit P-glycoprotein activity in vitro, Neuropsychopharmacology 32 (2007) 757-764.
16. C. Ampasavate, U. Sotanaphun, P. Phattanawasin, N. Piyapolrungroj, Effects of Curcuma spp. on P-glycoprotein function, Phytomedicine 17 (2010) 506-512.
17. B. Raay, S. Medda, S. Mukhopadhyay, M.K. Basu, Targeting of piperine intercalated in mannose-coated liposomes in experimental leishmaniasis, Indian J. Biochem. Biophys. 36 (1999) 248-251.
18. K. Vaibhav, P. Shrivastava, H. Javed, A. Khan, M.E. Ahmed, R. Tabassum, M.M. Khan, G. Khuwaja, F. Islam, M.S. Siddiqui, M.M. Safhi, Piperine suppresses cerebral ischemia-reperfusion-induced inflammation through the repression of COX-2, NOS-2, and NF-kappaB in middle cerebral artery occlusion rat model, Mol. Cell. Biochem. 367 (2012) 73-84.
19. S. Li, C. Wang, M.W. Wang, W. Li, K. Matsumoto, Y.Y. Tang, Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms, Life Sci. 80 (2007) 1373-1381.
20. C.D. Doucette, A.L. Hilchie, R. Liwski, D.W. Hoskin, Piperine, a dietary phytochemical, inhibits angiogenesis, J. Nutr. Biochem. 24 (2013) 231-239.
21. A. Khajuria, N. Thusu, U. Zutshi, K.L. Bedi, Piperine modulation of carcinogen induced oxidative stress in intestinal mucosa, Mol. Cell. Biochem. 189 (1998) 113-118.
22. C.R. Pradeep, G. Kuttan, Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice, Clin. Exp. Metastasis 19 (2002) 703-708.
23. D.P. Bezerra, F.O. Castro, A.P.N.N. Alves, C. Pessoa, M.O. Moraes, E.R. Silveira, M.A.S. Lima, F.J.M. Elmiro, L.V. Costa-Lotufo, In vivo growth-inhibition of sarcoma 180 by piplartine and piperine, two alkaloid amides from piper, Braz. J. Med. Biol. Res. 39 (2006) 801-807.
24. L.H. Lai, Q.H. Fu, Y. Liu, K. Jiang, Q.M. Guo, Q.Y. Chen, B. Yan, Q.Q. Wang, J.G. Shen, Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model, Acta Pharmacol. Sin. 33 (2012) 523-530.
25. R.K. Dogra, S. Khanna, R. Shanker, Immunotoxicological effects of piperine in mice, Toxicology 196 (2004) 229-236.
26. S. Chuchawankul, N. Khorana, Y. Poovorawan, Piperine inhibits cytokine production by human peripheral blood mononuclear cells, Genet. Mol. Res. 11 (2012) 617-627.
27. M.B. Daware, A.M. Mujumdar, S. Ghaskadbi, Reproductive toxicity of piperine in swiss albino mice, Planta Med. 66 (2000) 231-236.
28. N. Tyagi, S.S. Rathore, P.C. Ghosh, Enhanced killing of human epidermoid carcinoma (KB) cells by treatment with ricin encapsulated into sterically stabilized liposomes in combination with monensin, Drug Deliv. 18 (2011) 394-404.
29. N. Tyagi, P.C. Ghosh, Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated into folate-tagged liposomes, Eur. J. Pharm. Sci. 43 (2011) 343-353.
30. V.P. Torchilin, Passive and active drug targeting: drug delivery to tumors as an example, Handb. Exp. Pharmacol. 197 (2010) 3-53.
31. E. Flowers, R. Tice, M. Gilley, L. Dunn, B. Moore, Poly(DL- Lactide-co-glycol Ide)/Noreth Microcapsules: an Injectable Biodegradable Isterone Contraceptive Reports, 1983, pp. 186-195.
32. R. Dinarvand, N. Sepehri, S. Manoochehri, H. Rouhani, F. Atyabi, Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents, Int. J. Nanomed. 6 (2011) 877-895.
33. V. Gupta, A. Aseh, C.N. Rios, B.B. Aggarwal, A.B. Mathur, Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy, Int. J. Nanomed. 4 (2009) 115-122.
34. J. Kim, J.E. Lee, S.H. Lee, J.H. Yu, J.H. Lee, T.G. Park, T. Hyeon, Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery, Adv. Mater. 20 (2008), 478-4.
35. W.S. Kuo, Y.C. Ku, H.T. Sei, F.Y. Cheng, C.S. Yeh, Paclitaxel-loaded stabilizer-free poly(D,L-lactide-co-glycolide) nanoparticles conjugated with quantum dots for reversion of anti-cancer drug resistance and cancer cellular imaging, J. Chin. Chem. Soc. Taip. 56 (2009) 923-934.
36. Y.J. He, T.T. Lin, L.M. Zhu, H. Luo, J. Chang, H. Zhang, H.M. Zhang, VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma, Zhonghua Yan Ke Za Zhi 46 (2010) 795-801.
37. V. Bagalkot, O.C. Farokhzad, R. Langer, S. Jon, An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform, Angew. Chem. Int. Ed. 45 (2006) 8149-8152.
38. A.C. Yan, M. Levy, Aptamers and aptamer targeted delivery, RNA Biol. 6 (2009) 316-320.
39. K.M. Song, S. Lee, C. Ban, Aptamers and their biological applications, Sensors 12 (2012) 612-631 (Basel).
40. R. Surolia, M. Pachauri, P.C. Ghosh, Preparation and characterization of monensin loaded PLGA nanoparticles: in vitro anti-malarial activity against Plasmodium Falciparum, J. Biomed. Nanotechnol. 8 (2012) 172-181.
41. S.J. Park, C.H. Wu, A.R. Safa, A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways, Anticancer Res. 24 (2004) 123-131.
42. N. Feller, C.M. Kuiper, J. Lankelma, J.K. Ruhdal, R.J. Scheper, H.M. Pinedo, H.J. Broxterman, Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry, Br. J. Cancer 72 (1995) 543-549.
43. P. Pozarowski, Z. Darzynkiewicz, Analysis of cell cycle by flow cytometry, Methods Mol. Biol. 281 (2004) 301-311.
44. A. Bhardwaj, S.K. Srivastava, S. Singh, S. Arora, N. Tyagi, J. Andrews, S. McClellan, J.E. Carter, A.P. Singh, CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1, Oncotarget 5 (2014) 11490-11500.
45. N. Tyagi, A. Bhardwaj, A.P. Singh, S. McClellan, J.E. Carter, S. Singh, p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway, Oncotarget 5 (2014) 8778-8789.
46. S.K. Srivastava, A. Bhardwaj, S. Arora, N. Tyagi, A.P. Singh, J.E. Carter, J.G. Scammell, O. Fodstad, S. Singh, Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis, Br. J. Cancer 112 (2015) 1772-1781.
47. S.K. Deshmukh, S.K. Srivastava, A. Bhardwaj, A.P. Singh, N. Tyagi, S. Marimuthu, D.L. Dyess, V. Dal Zotto, J.E. Carter, S. Singh, Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation, Oncotarget 6 (2015) 11231-11241.
48. C.C. Liang, A.Y. Park, J.L. Guan, In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro, Nat. Protoc. 2 (2007) 329-333.
49. C.D. Medley, S. Bamrungsap, W. Tan, J.E. Smith, Aptamer-conjugated nano-particles for cancer cell detection, Anal. Chem. 83 (2011) 727-734.
50. S. Arora, N. Tyagi, A. Bhardwaj, L. Rusu, R. Palanki, K. Vig, S.R. Singh, A.P. Singh, S. Palanki, M.E. Miller, J.E. Carter, S. Singh, Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis, Nanomedicine 11 (2015) 1265-1275.
51. N. Tyagi, S.S. Rathore, P.C. Ghosh, Efficacy of liposomal monensin on the enhancement of the antitumour activity of liposomal ricin in human epider-moid carcinoma (KB) cells, Indian J. Pharm. Sci. 75 (2013) 16-22.
52. D. Kim, H. El-Shall, D. Dennis, T. Morey, Interaction of PLGA nanoparticles with human blood constituents, Colloids Surf. B Biointerfaces 40 (2005) 83-91.
53. P.R. Veerareddy, V. Vobalaboina, Pharmacokinetics and tissue distribution of piperine lipid nanospheres, Pharmazie 63 (2008) 352-355.
54. S. Bajad, A.K. Singla, K.L. Bedi, Liquid chromatographic method for determination of piperine in rat plasma: application to pharmacokinetics, J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 776 (2002) 245-249.
55. S.C. Wu, K.L. Lin, T.P. Wang, S.C. Tzou, G. Singh, M.H. Chen, T.L. Cheng, C.Y. Chen, G.C. Liu, T.W. Lee, S.H. Hu, Y.M. Wang, Imaging specificity of MR-optical imaging agents following the masking of surface charge by poly(-ethylene glycol), Biomaterials 34 (2013) 4118-4127.
56. S. Fredenberg, M. Wahlgren, M. Reslow, A. Axelsson, The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systemsea review, Int. J. Pharm. 415 (2011) 34-52.
57. Z. Zarai, E. Boujelbene, N. Ben Salem, Y. Gargouri, A. Sayari, Antioxidant and antimicrobial activities of various solvent extracts, piperine and piperic acid from Piper nigrum, Lwt-Food Sci. Technol. 50 (2013) 634-641.
58. O.I. Corrigan, X. Li, Quantifying drug release from PLGA nanoparticulates, Eur. J. Pharm. Sci. 37 (2009) 477-485.
59. R. Trivedi, U.B. Kompella, Nanomicellar formulations for sustained drug delivery: strategies and underlying principles, Nanomedicine (Lond) 5 (2010) 485-505.
60. X. Yang, B. Zhu, T. Dong, P. Pan, X. Shuai, Y. Inoue, Interactions between an anticancer drug and polymeric micelles based on biodegradable polyesters, Macromol. Biosci. 8 (2008) 1116-1125.
61. S.K. Agrawal, N. Sanabria-DeLong, J.M. Coburn, G.N. Tew, S.R. Bhatia, Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock co-polymers, J. Control Release 112 (2006) 64-71.
62. D.Y. Ouyang, L.H. Zeng, H. Pan, L.H. Xu, Y. Wang, K.P. Liu, X.H. He, Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy, Food Chem. Toxicol. 60 (2013) 424-430.
63. C.W. Cho, Y. Liu, X. Yan, T. Henthorn, K.Y. Ng, Carrier-mediated uptake of rhodamine 123: implications on its use for MDR research, Biochem. Biophys. Res. Commun. 279 (2000) 124-130.
64. M.P. Desai, V. Labhasetwar, E. Walter, R.J. Levy, G.L. Amidon, The mechanism of uptake of biodegradable microparticles in caco-2 cells is size dependent, Pharm. Res. 14 (1997) 1568-1573.
65. M.G. Ormerod, The study of apoptotic cells by flow cytometry, Leukemia 12 (1998) 1013-1025.
66. S.K. Srivastava, A. Bhardwaj, S. Arora, N. Tyagi, S. Singh, J. Andrews, S. McClellan, B. Wang, A.P. Singh, MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways, Br. J. Cancer 113 (2015) 660-668.
67. C. Diaz, A.T. Lee, D.J. McConkey, A.J. Schroit, Phosphatidylserine externalization during differentiation-triggered apoptosis of erythroleukemic cells, Cell Death Differ. 6 (1999) 218-226.
68. F. Yan, Y. Jiang, Y.M. Li, X. Zhen, J. Cen, W.R. Fang, Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives, Biol. Pharm. Bull. 31 (2008) 1258-1264.
69. M.B. Sporn, The war on cancer, Lancet 347 (1996) 1377-1381.
70. M.A. Cheever, J.P. Allison, A.S. Ferris, O.J. Finn, B.M. Hastings, T.T. Hecht, I. Mellman, S.A. Prindiville, J.L. Viner, L.M. Weiner, L.M. Matrisian, The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research, Clin. Cancer Res. 15 (2009) 5323-5337.
71. D.W. Kufe, MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches, Oncogene 32 (2013) 1073-1081.
72. K.Y. Wang, S. McCurdy, R.G. Shea, S. Swaminathan, P.H. Bolton, A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA, Biochemistry 32 (1993) 1899-1904.
73. L. Cerchia, J. Hamm, D. Libri, B. Tavitian, V. de Franciscis, Nucleic acid aptamers in cancer medicine, FEBS Lett. 528 (2002) 12-16.